The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Reichling Steven since 2015.
This trader's CIK number is 1556290.
At the time of last reporting, Reichling Steven was the Chief Financial Officer of Accelerate Diagnostics, Inc. (stock ticker symbol AXDX).
Also see all insider trading activities at Accelerate Diagnostics, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | AXDX | 0 | $0 | 77,039 | $37,967 | 151,916 | $0 |
| 2022 | AXDX | 5,000 | $6,949 | 29,915 | $29,316 | 57,736 | $0 |
| 2021 | AXDX | 0 | $0 | 79,833 | $974,111 | 101,205 | $210,598 |
| 2020 | AXDX | 1,000 | $6,920 | 39,329 | $373,625 | 49,329 | $147,000 |
| 2018 | AXDX | 1,600 | $22,200 | 0 | $0 | 0 | $0 |
| 2017 | AXDX | 0 | $0 | 30,000 | $867,000 | 30,000 | $89,400 |
| 2015 | AXDX | 600 | $9,138 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-13 | AXDX | Option Ex | 9,438 | .00 | 0 |
| 2023-03-13 | AXDX | Sale | 4,708 | .49 | 2,306 |
| 2023-03-08 | AXDX | Option Ex | 123,600 | .00 | 0 |
| 2023-03-08 | AXDX | Sale | 62,778 | .47 | 29,505 |
| 2023-02-13 | AXDX | Option Ex | 9,439 | .00 | 0 |
| 2023-02-13 | AXDX | Sale | 4,823 | .60 | 2,893 |
| 2023-01-13 | AXDX | Sale | 4,730 | .69 | 3,263 |
| 2023-01-13 | AXDX | Option Ex | 9,439 | .00 | 0 |
| 2022-08-22 | AXDX | Buy | 5,000 | 1.39 | 6,949 |
| 2022-04-26 | AXDX | Option Ex | 57,736 | .00 | 0 |
| 2022-04-28 | AXDX | Sale | 29,915 | .98 | 29,316 |
| 2021-05-12 | AXDX | Option Ex | 27,392 | .00 | 0 |
| 2021-05-13 | AXDX | Sale | 8,303 | 6.76 | 56,128 |
| 2020-12-17 | AXDX | Sale | 859 | 7.37 | 6,330 |
| 2020-12-16 | AXDX | Option Ex | 3,142 | .00 | 0 |
| 2021-01-25 | AXDX | Option Ex | 20,761 | 2.98 | 61,867 |
| 2021-01-26 | AXDX | Option Ex | 24,910 | 2.98 | 74,231 |
| 2021-01-25 | AXDX | Sale | 20,761 | 10.55 | 219,028 |
| 2021-01-27 | AXDX | Option Ex | 25,000 | 2.98 | 74,500 |
| 2021-01-26 | AXDX | Sale | 24,910 | 12.50 | 311,375 |
| 2021-01-27 | AXDX | Sale | 25,000 | 15.25 | 381,250 |
| 2020-11-09 | AXDX | Option Ex | 39,329 | 2.98 | 117,200 |
| 2020-11-09 | AXDX | Sale | 39,329 | 9.50 | 373,625 |
| 2020-03-19 | AXDX | Buy | 1,000 | 6.92 | 6,920 |
| 2020-02-27 | AXDX | Option Ex | 10,000 | 2.98 | 29,800 |
| 2018-11-27 | AXDX | Buy | 850 | 13.13 | 11,160 |
| 2018-11-08 | AXDX | Buy | 750 | 14.72 | 11,040 |
| 2017-06-21 | AXDX | Sale | 30,000 | 28.90 | 867,000 |
| 2017-06-21 | AXDX | Option Ex | 30,000 | 2.98 | 89,400 |
| 2015-09-29 | AXDX | Buy | 600 | 15.23 | 9,138 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reichling Steven (Chief Financial Officer of Accelerate Diagnostics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.